{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:06:35Z","timestamp":1793084795309,"version":"4.5.0"},"reference-count":344,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,18]]},"abstract":"Abstract<\/jats:title>\n \n BACKGROUND<\/jats:title>\n Menopausal symptoms can be very distressing and considerably affect a woman\u2019s personal and social life. It is becoming more and more evident that leaving bothersome symptoms untreated in midlife may lead to altered quality of life, reduced work productivity and, possibly, overall impaired health. Hormone therapy (HT) for the relief of menopausal symptoms has been the object of much controversy over the past two decades. At the beginning of the century, a shadow was cast on the use of HT owing to the concern for cardiovascular and cerebrovascular risks, and breast cancer, arising following publication of a large randomized placebo-controlled trial. Findings of a subanalysis of the trial data and extended follow-up studies, along with other more modern clinical trials and observational studies, have provided new evidence on the effects of HT.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVE AND RATIONALE<\/jats:title>\n The goal of the following paper is to appraise the most significant clinical literature on the effects of hormones in postmenopausal women, and to report the benefits and risks of HT for the relief of menopausal symptoms.<\/jats:p>\n <\/jats:sec>\n \n SEARCH METHODS<\/jats:title>\n A Pubmed search of clinical trials was performed using the following terms: estrogens, progestogens, bazedoxifene, tibolone, selective estrogen receptor modulators, tissue-selective estrogen complex, androgens, and menopause.<\/jats:p>\n <\/jats:sec>\n \n OUTCOMES<\/jats:title>\n HT is an effective treatment for bothersome menopausal vasomotor symptoms, genitourinary syndrome, and prevention of osteoporotic fractures. Women should be made aware that there is a small increased risk of stroke that tends to persist over the years as well as breast cancer risk with long-term estrogen\u2013progestin use. However, healthy women who begin HT soon after menopause will probably earn more benefit than harm from the treatment. HT can improve bothersome symptoms, all the while conferring offset benefits such as cardiovascular risk reduction, an increase in bone mineral density and a reduction in bone fracture risk. Moreover, a decrease in colorectal cancer risk is obtainable in women treated with estrogen\u2013progestin therapy, and an overall but nonsignificant reduction in mortality has been observed in women treated with conjugated equine estrogens alone or combined with estrogen\u2013progestin therapy. Where possible, transdermal routes of HT administration should be preferred as they have the least impact on coagulation. With combined treatment, natural progesterone should be favored as it is devoid of the antiapoptotic properties of other progestogens on breast cells. When beginning HT, low doses should be used and increased gradually until effective control of symptoms is achieved. Unless contraindications develop, patients may choose to continue HT as long as the benefits outweigh the risks. Regular reassessment of the woman\u2019s health status is mandatory. Women with premature menopause who begin HT before 50\u2009years of age seem to have the most significant advantage in terms of longevity.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS<\/jats:title>\n In women with bothersome menopausal symptoms, HT should be considered one of the mainstays of treatment. Clinical practitioners should tailor HT based on patient history, physical characteristics, and current health status so that benefits outweigh the risks.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humupd\/dmab026","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:08:38Z","timestamp":1625900918000},"page":"1115-1150","source":"Crossref","is-referenced-by-count":90,"title":["Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4260-3929","authenticated-orcid":false,"given":"Andrea R","family":"Genazzani","sequence":"first","affiliation":[{"name":"Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Monteleone","sequence":"additional","affiliation":[{"name":"Azienda USL Toscana Nord Ovest, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-4435","authenticated-orcid":false,"given":"Andrea","family":"Giannini","sequence":"additional","affiliation":[{"name":"Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[{"name":"Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"2021102505540101800_dmab026-B1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.fertnstert.2016.10.028","article-title":"Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis","volume":"107","author":"Achilli","year":"2017","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0378-5122(90)90013-V","article-title":"Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in postmenopausal women","volume":"12","author":"Aedo","year":"1990","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B3","doi-asserted-by":"crossref","first-page":"e0207509","DOI":"10.1371\/journal.pone.0207509","article-title":"Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: findings from the Women's Health Initiative","volume":"13","author":"Al-Rousan","year":"2018","journal-title":"PLoS One"},{"key":"2021102505540101800_dmab026-B4","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"ACOG Committee Opinion No. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer","volume":"127","author":"Farrell","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women\u2019s Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/eje.0.1480571","article-title":"Progesterone effects during sequential hormone replacement therapy","volume":"148","author":"Andr\u00e9en","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2021102505540101800_dmab026-B7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsbmb.2014.09.003","article-title":"Dehydroepiandrosterone intravaginal administration for the management of postmenopausal vulvovaginal atrophy","volume":"145","author":"Archer","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2021102505540101800_dmab026-B8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/gme.0b013e3181948dd0","article-title":"Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women\u2019s Health Across the Nation","volume":"16","author":"Avis","year":"2009","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2021102505540101800_dmab026-B10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/GME.0000000000000770","article-title":"Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation","volume":"24","author":"Avis","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bone.2003.12.021","article-title":"Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study","volume":"34","author":"Bagger","year":"2004","journal-title":"Bone"},{"key":"2021102505540101800_dmab026-B13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00042192-200512010-00005","article-title":"Early postmenopausal hormone therapy may prevent cognitive impairment later in life","volume":"12","author":"Bagger","year":"2005","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.25314","article-title":"Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition","volume":"128","author":"Bakken","year":"2011","journal-title":"Int J Cancer"},{"key":"2021102505540101800_dmab026-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-2994-7","article-title":"Breast cancer and aging: results of the U13 conference breast cancer panel","volume":"146","author":"Barginear","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"2021102505540101800_dmab026-B16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Women's Health Initiative Investigators. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women\u2019s Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1258\/mi.2009.009013","article-title":"Intervertebral disc height correlates with vertebral body T-scores in premenopausal and postmenopausal women","volume":"15","author":"Baron","year":"2009","journal-title":"Menopause Int"},{"key":"2021102505540101800_dmab026-B18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1373\/clinchem.2013.202556","article-title":"Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification","volume":"60","author":"Bassuk","year":"2014","journal-title":"Clin Chem"},{"key":"2021102505540101800_dmab026-B20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/gme.0b013e3181e3aab1","article-title":"Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials","volume":"18","author":"Bea","year":"2011","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000095400","article-title":"Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels","volume":"83","author":"Bernardi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"2021102505540101800_dmab026-B25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/aje\/kwx131","article-title":"Hormone therapy use and risk of chronic disease in the Nurses' Health Study: a comparative analysis with the women's health initiative","volume":"186","author":"Bhupathiraju","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2021102505540101800_dmab026-B26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/GME.0000000000001284","article-title":"Vaginal estrogen use and chronic disease risk in the Nurses' Health Study","volume":"26","author":"Bhupathiraju","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3109\/09513590.2010.495437","article-title":"Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1067\/mob.2000.107781","article-title":"Negative mood changes during hormone replacement therapy: a comparison between two progestogens","volume":"183","author":"Bj\u00f6rn","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/gye.16.1.1.8","article-title":"The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy","volume":"16","author":"Bj\u00f6rn","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/GME.0000000000000541","article-title":"The effect of conjugated estrogens\/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trials","volume":"23","author":"Black","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"2021102505540101800_dmab026-B32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/13697137.2011.624215","article-title":"What are the real risks for breast cancer?","volume":"15","author":"Bluming","year":"2012","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/GME.0000000000001137","article-title":"Physical performance in relation to menopause status and physical activity","volume":"25","author":"Bondarev","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/eurheartj\/ehi695","article-title":"The effect of tibolone and continuous combined conjugated equine estrogens plus medroxyprogesterone acetate on progression of carotid intima\/media thickness: the osteoporosis prevention and arterial effects of tibolone (OPAL) study","volume":"27","author":"Bots","year":"2006","journal-title":"Eur Heart J"},{"key":"2021102505540101800_dmab026-B35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2019.04.213","article-title":"Female reproductive factors and the likelihood of reaching the age of 90 years. The Netherlands Cohort Study","volume":"125","author":"Brandts","year":"2019","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B36","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"165","author":"Braunstein","year":"2005","journal-title":"Arch Intern Med"},{"key":"2021102505540101800_dmab026-B37","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.amjcard.2008.01.043","article-title":"Women's Health Initiative Investigators. Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events","volume":"101","author":"Bray","year":"2008","journal-title":"Am J Cardiol"},{"key":"2021102505540101800_dmab026-B38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tins.2008.07.003","article-title":"The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications","volume":"31","author":"Brinton","year":"2008","journal-title":"Trends Neurosci"},{"key":"2021102505540101800_dmab026-B39","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/archinte.165.17.1976","article-title":"Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial","volume":"165","author":"Brunner","year":"2005","journal-title":"Arch Intern Med"},{"key":"2021102505540101800_dmab026-B40","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/gme.0b013e3181d76953","article-title":"Menopausal symptom experience before and after stopping estrogen therapy in the Women\u2019s Health Initiative randomized, placebo-controlled trial","volume":"17","author":"Brunner","year":"2010","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/GME.0000000000000772","article-title":"Treating schizophrenia during menopause","volume":"24","author":"Brzezinski","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B42","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr3097","article-title":"Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy","volume":"14","author":"Bundred","year":"2012","journal-title":"Breast Cancer Res"},{"key":"2021102505540101800_dmab026-B43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.75.6.1102","article-title":"Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study","volume":"75","author":"Bush","year":"1987","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial","volume":"105","author":"Buster","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpobgyn.2013.06.004","article-title":"Skin connective tissue and ageing","volume":"27","author":"Calleja-Agius","year":"2013","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2021102505540101800_dmab026-B46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GME.0000000000000296","article-title":"Hormone therapy and hemostasis among postmenopausal women: a review","volume":"21","author":"Canonico","year":"2014","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B48","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/STROKEAHA.116.013052","article-title":"Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen","volume":"47","author":"Canonico","year":"2016","journal-title":"Stroke"},{"key":"2021102505540101800_dmab026-B326","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021102505540101800_dmab026-B49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/13697137.2015.1083003","article-title":"MsFLASH participants\u2019 priorities for alleviating menopausal symptoms","volume":"18","author":"Carpenter","year":"2015","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B50","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/jc.2014-3301","article-title":"Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials","volume":"100","author":"Casanova","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B51","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Women\u2019s Health Initiative Investigators: effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Cauley","year":"2006","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B53","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archsurg.137.9.1015","article-title":"The impact of hormone replacement therapy on the detection and stage of breast cancer","volume":"137","author":"Cheek","year":"2002","journal-title":"Arch Surg"},{"key":"2021102505540101800_dmab026-B54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-137-10-200211190-00008","article-title":"Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer","volume":"137","author":"Chen","year":"2002","journal-title":"Ann Intern Med"},{"key":"2021102505540101800_dmab026-B55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"2021102505540101800_dmab026-B56","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamaoncol.2015.0494","article-title":"Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 Women's Health Initiative Randomized Clinical Trials","volume":"1","author":"Chlebowski","year":"2015","journal-title":"JAMA Oncol"},{"key":"2021102505540101800_dmab026-B58","doi-asserted-by":"crossref","first-page":"djv350","DOI":"10.1093\/jnci\/djv350","article-title":"Continuous combined estrogen plus progestin and endometrial cancer: the Women's Health Initiative Randomized Trial","volume":"108","author":"Chlebowski","year":"2015","journal-title":"Jncij"},{"key":"2021102505540101800_dmab026-B59","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/GME.0000000000001235","article-title":"Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial","volume":"25","author":"Chlebowski","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B60","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00404-019-05059-2","article-title":"Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia","volume":"299","author":"Ciccone","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"2021102505540101800_dmab026-B61","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12020-016-1072-9","article-title":"Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis","volume":"55","author":"Cintron","year":"2017","journal-title":"Endocrine"},{"key":"2021102505540101800_dmab026-B62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/GME.0000000000000971","article-title":"Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)","volume":"25","author":"Cintron","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B63","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.22138","article-title":"Effect of hormone therapy on risk of hip and knee joint replacement in the Women\u2019s Health Initiative","volume":"54","author":"Cirillo","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021102505540101800_dmab026-B64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/GME.0b013e31803c764d","article-title":"Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression","volume":"14","author":"Clarkson","year":"2007","journal-title":"Menopause N Menopause"},{"key":"2021102505540101800_dmab026-B65","first-page":"CD001405","article-title":"Estrogen therapy for urinary incontinence in post-menopausal women","volume":"10","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B66","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B67","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCULATIONAHA.108.817577","article-title":"Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors","volume":"119","author":"Collins","year":"2009","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B68","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1080\/03007995.2018.1527578","article-title":"Estradiol vaginal inserts (4\u2009\u00b5g and 10\u2009\u00b5g) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data","volume":"34","author":"Constantine","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2021102505540101800_dmab026-B69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jwh.2018.6956","article-title":"Increased incidence of endometrial cancer following the Women's Health Initiative: an assessment of risk factors","volume":"28","author":"Constantine","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"2021102505540101800_dmab026-B70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-011-1394-5","article-title":"Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells","volume":"131","author":"Courtin","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2021102505540101800_dmab026-B71","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.2014-3062","article-title":"Associations of menopausal vasomotor symptoms with fracture incidence","volume":"100","author":"Crandall","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B72","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/GME.0000000000000899","article-title":"Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study","volume":"24","author":"Crandall","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B74","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/gme.0b013e31824790a6","article-title":"Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women\u2019s Health Study","volume":"19","author":"Cray","year":"2012","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B75","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B76","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/rth2.12100","article-title":"Biomarkers, menopausal hormone therapy and risk of venous thrombosis: the Women's Health Initiative","volume":"2","author":"Cushman","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"2021102505540101800_dmab026-B78","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"SERM Chemoprevention of Breast Cancer Overview Group. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B79","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/ije\/dyv165","article-title":"men: menopause vs age effects","volume":"44","author":"Dalg\u00e5rd","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2021102505540101800_dmab026-B80","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2018-01345","article-title":"Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors","volume":"103","author":"Davis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B81","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13697137.2019.1637079","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"22","author":"Davis","year":"2019","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B82","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00125-009-1456-y","article-title":"Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Generale de l\u2019Education Nationale (E3N) cohort","volume":"52","author":"de Lauzon-Guillain","year":"2009","journal-title":"Diabetologia"},{"key":"2021102505540101800_dmab026-B83","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2016.07.040","article-title":"Depression during the perimenopause: a meta-analysis","volume":"206","author":"de Kruif","year":"2016","journal-title":"J Affect Disord"},{"key":"2021102505540101800_dmab026-B85","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2014.5177","article-title":"The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and western Europe","volume":"24","author":"Di Bonaventura","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"2021102505540101800_dmab026-B86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2018.11.016","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2018.11.017","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part II: evaluation of tolerability and safety","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B88","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2011.36.8134","article-title":"Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1\/2-associated breast cancer","volume":"29","author":"Domchek","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021102505540101800_dmab026-B89","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(00)01768-4","article-title":"Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy","volume":"75","author":"D\u00f6ren","year":"2001","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B90","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/GME.0b013e318291f5a6","article-title":"Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms","volume":"20","author":"Drogos","year":"2013","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B91","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/jwh.2017.6637","article-title":"Prescribing bioidentical menopausal hormone therapy: a survey of physician views and practices","volume":"27","author":"Dubaut","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"2021102505540101800_dmab026-B943189848","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2021102505540101800_dmab026-B92","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacl.2016.04.008","article-title":"Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression","volume":"10","author":"El Khoudary","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2021102505540101800_dmab026-B93","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2005.09.083","article-title":"Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis","volume":"97","author":"Ensrud","year":"2006","journal-title":"Am J Cardiol"},{"key":"2021102505540101800_dmab026-B94","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.21.10.1589","article-title":"Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Postmenopausal Estrogen\/Progestin Interventions","volume":"21","author":"Espeland","year":"1998","journal-title":"Diabetes Care"},{"key":"2021102505540101800_dmab026-B95","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamainternmed.2013.7727","article-title":"Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years","volume":"173","author":"Espeland","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2021102505540101800_dmab026-B96","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.maturitas.2007.02.008","article-title":"Tibolone for prevention and treatment of postmenopausal osteoporosis","volume":"57","author":"Ettinger","year":"2007","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B98","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bjc.6602472","article-title":"Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study","volume":"92","author":"Ewertz","year":"2005","journal-title":"Br J Cancer"},{"key":"2021102505540101800_dmab026-B99","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2007-1876","article-title":"Bone mineral density changes during the menopause transition in a multiethnic cohort of women","volume":"93","author":"Finkelstein","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/15246090050020691","article-title":"Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey","volume":"9","author":"Fitzpatrick","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"2021102505540101800_dmab026-B101","first-page":"CD008536","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"2021102505540101800_dmab026-B103","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-014-2934-6","article-title":"Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort","volume":"145","author":"Fournier","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"2021102505540101800_dmab026-B104","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF03347261","article-title":"Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women","volume":"28","author":"Francucci","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2021102505540101800_dmab026-B105","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/AOG.0b013e318214f0de","article-title":"Duration of menopausal hot flushes and associated risk factors","volume":"117","author":"Freeman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2004.04.006","article-title":"Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women","volume":"50","author":"Gambacciani","year":"2005","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.maturitas.2007.10.007","article-title":"Ultra-low-dose hormone replacement therapy and bone protection in postmenopausal women","volume":"59","author":"Gambacciani","year":"2008","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B108","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/GME.0000000000001237","article-title":"Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years","volume":"25","author":"Gartoulla","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B109","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/gme.0b013e3182227ebd","article-title":"Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative","volume":"18","author":"Gass","year":"2011","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/GME.0000000000000994","article-title":"Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials","volume":"25","author":"Gass","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B111","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/humupd\/dmx011","article-title":"The management of menopause in women with a history of endometriosis: a systematic review","volume":"23","author":"Gemmell","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2021102505540101800_dmab026-B112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09513590600629092","article-title":"Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution","volume":"22","author":"Genazzani","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B113","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/09513590601024681","article-title":"Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women","volume":"22","author":"Genazzani","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humupd\/dml042","article-title":"Estrogen, cognition and female ageing","volume":"13","author":"Genazzani","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2021102505540101800_dmab026-B115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/13697137.2011.579649","article-title":"Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality","volume":"14","author":"Genazzani","year":"2011","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B116","doi-asserted-by":"crossref","first-page":"e1001833","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized controlled KEEPS-Cognitive and Affective Study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Med"},{"key":"2021102505540101800_dmab026-B117","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jwh.2009.1384","article-title":"Recognizing and treating urogenital atrophy in postmenopausal women","volume":"19","author":"Goldstein","year":"2010","journal-title":"J Womens Health"},{"key":"2021102505540101800_dmab026-B118","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol Oncol"},{"key":"2021102505540101800_dmab026-B119","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/2167702616647924","article-title":"Naturally occurring changes in estradiol concentrations in the menopause transition predict morning cortisol and negative mood in perimenopausal depression","volume":"4","author":"Gordon","year":"2016","journal-title":"Clin Psychol Sci"},{"key":"2021102505540101800_dmab026-B120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2021102505540101800_dmab026-B121","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/oby.2006.120","article-title":"Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use","volume":"14","author":"Gower","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"2021102505540101800_dmab026-B122","first-page":"116","article-title":"Postmenopausal hormones and incontinence: the Heart and Estrogen\/Progestin Replacement Study","volume":"97","author":"Grady","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B123","first-page":"1233","article-title":"Predictors of difficulty when discontinuing postmenopausal hormone therapy","volume":"102","author":"Grady","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B124","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djn153","article-title":"Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk","volume":"100","author":"Grady","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2021102505540101800_dmab026-B125","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.0b013e3181a71193","article-title":"Effects of the menopause transition and hormone use on cognitive performance in midlife women","volume":"72","author":"Greendale","year":"2009","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.maturitas.2015.12.005","article-title":"EMAS recommendations for conditions in the workplace for menopausal women","volume":"85","author":"Griffiths","year":"2016","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B127","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-128-9-199805010-00001","article-title":"Postmenopausal hormone use and risk for colorectal cancer and adenoma","volume":"128","author":"Grodstein","year":"1998","journal-title":"Ann Intern Med"},{"key":"2021102505540101800_dmab026-B128","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"2021102505540101800_dmab026-B129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.168.8.861","article-title":"Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy","volume":"168","author":"Grodstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"2021102505540101800_dmab026-B130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1471-0528.2007.01537.x","article-title":"Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability","volume":"114","author":"Hammar","year":"2007","journal-title":"BJOG"},{"key":"2021102505540101800_dmab026-B131","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/physrev.00036.2014","article-title":"Estrogen effects on cognitive and synaptic health over the lifecourse","volume":"95","author":"Hara","year":"2015","journal-title":"Physiol Rev"},{"key":"2021102505540101800_dmab026-B132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/13697137.2011.650656","article-title":"Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging","volume":"15","author":"Harlow","year":"2012","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B133","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"Harman","year":"2014","journal-title":"Ann Intern Med"},{"key":"2021102505540101800_dmab026-B134","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/gme.0b013e31818fbff5","article-title":"Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?","volume":"16","author":"Haskell","year":"2009","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B135","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B136","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2021102505540101800_dmab026-B137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy","volume":"151","author":"Henderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"2021102505540101800_dmab026-B138","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.2003.024927","article-title":"Postmenopausal hormone therapy and Alzheimer\u2019s disease risk: interaction with age","volume":"76","author":"Henderson","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021102505540101800_dmab026-B139","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","article-title":"Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis","volume":"87","author":"Henderson","year":"2016","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with and without progestin on urinary incontinence","volume":"293","author":"Hendrix","year":"2005","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B141","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1210\/jc.2017-00825","article-title":"Estradiol therapy after menopause mitigates effects of stress on cortisol and working memory","volume":"102","author":"Herrera","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B142","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B143","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1471-0528.15433","article-title":"Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort","volume":"126","author":"Holm","year":"2019","journal-title":"BJOG"},{"key":"2021102505540101800_dmab026-B144","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2021102505540101800_dmab026-B146","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1359\/jbmr.070707","article-title":"Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women","volume":"22","author":"Huang","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2021102505540101800_dmab026-B147","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B148","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2021102505540101800_dmab026-B149","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0000000000003696","article-title":"Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study","volume":"88","author":"Imtiaz","year":"2017","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B150","doi-asserted-by":"crossref","first-page":"e54713","DOI":"10.1371\/journal.pone.0054713","article-title":"Accelerated cell aging in female APOE-\u03b54 carriers: implications for hormone therapy use","volume":"8","author":"Jacobs","year":"2013","journal-title":"PLoS One"},{"key":"2021102505540101800_dmab026-B151","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-09-0619","article-title":"Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial","volume":"162","author":"Jacobsen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2021102505540101800_dmab026-B152","doi-asserted-by":"crossref","first-page":"13065","DOI":"10.1016\/S0021-9258(17)36796-0","article-title":"Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein","volume":"269","author":"Jaffe","year":"1994","journal-title":"J Biol Chem"},{"key":"2021102505540101800_dmab026-B153","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1359\/jbmr.2003.18.2.333","article-title":"Hormone replacement therapy dissociates fat mass and bone mass and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study","volume":"18","author":"Jensen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2021102505540101800_dmab026-B154","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/bjc.2016.231","article-title":"Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?","volume":"115","author":"Jones","year":"2016","journal-title":"Br J Cancer"},{"key":"2021102505540101800_dmab026-B155","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-14-0448","article-title":"The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer","volume":"22","author":"Jordan","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"2021102505540101800_dmab026-B156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"2021102505540101800_dmab026-B157","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/01.WNL.0000132522.13574.67","article-title":"Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women","volume":"63","author":"Kang","year":"2004","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B158","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/gme.0b013e31821b01c7","article-title":"Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization","volume":"18","author":"Karim","year":"2011","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B159","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1532-5415.2005.53567.x","article-title":"Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women","volume":"53","author":"Kenny","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"2021102505540101800_dmab026-B160","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2003.05.151","article-title":"Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population","volume":"21","author":"Kerlikowske","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021102505540101800_dmab026-B161","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.bcp.2013.09.024","article-title":"Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease","volume":"86","author":"Khalil","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"2021102505540101800_dmab026-B162","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/GME.0000000000000824","article-title":"Association of sleep disturbance and sexual function in postmenopausal women","volume":"24","author":"Kling","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B163","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.amjcard.2007.01.042","article-title":"Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris","volume":"99","author":"Knuuti","year":"2007","journal-title":"Am J Cardiol"},{"key":"2021102505540101800_dmab026-B164","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.steroids.2014.06.004","article-title":"Development of conjugated estrogens\/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss","volume":"90","author":"Komm","year":"2014","journal-title":"Steroids"},{"key":"2021102505540101800_dmab026-B165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/13697137.2014.992011","article-title":"Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials","volume":"18","author":"Komm","year":"2015","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B166","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"key":"2021102505540101800_dmab026-B167","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ogc.2011.06.002","article-title":"Sleep during the perimenopause: a SWAN story","volume":"38","author":"Kravitz","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2021102505540101800_dmab026-B168","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopsycho.2004.11.009","article-title":"Sex differences in HPA axis responses to stress: a review","volume":"69","author":"Kudielka","year":"2005","journal-title":"Biol Psychol"},{"key":"2021102505540101800_dmab026-B169","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.18632\/aging.101558","article-title":"Reproductive history and blood cell telomere length","volume":"10","author":"Kresovich","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"2021102505540101800_dmab026-B170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/gme.0b013e31819e85c6","article-title":"Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B171","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jsm.13045","article-title":"Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J Sex Med"},{"key":"2021102505540101800_dmab026-B172","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0000000000000571","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B173","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/GME.0000000000001232","article-title":"Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy","volume":"25","author":"Lalibert\u00e9","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B174","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00125-004-1328-4","article-title":"Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women","volume":"47","author":"Lasco","year":"2004","journal-title":"Diabetologia"},{"key":"2021102505540101800_dmab026-B175","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2008-0701","article-title":"Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study","volume":"94","author":"Lee","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B176","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1073\/pnas.1604558113","article-title":"Menopause accelerates biological aging","volume":"113","author":"Levine","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021102505540101800_dmab026-B177","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainres.2010.10.033","article-title":"Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline","volume":"1379","author":"Lin","year":"2011","journal-title":"Brain Res"},{"key":"2021102505540101800_dmab026-B178","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B179","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jacc.2007.03.009","article-title":"Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study","volume":"49","author":"Loria","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2021102505540101800_dmab026-B180","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B181","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1210\/js.2019-00074","article-title":"Conjugated estrogens and bazedoxifene improve \u03b2 cell function in obese menopausal women","volume":"3","author":"Lovre","year":"2019","journal-title":"J Endocr Soc"},{"key":"2021102505540101800_dmab026-B182","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B183","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol-progestogen therapy","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B184","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2053369117731172","article-title":"Migraine, menopause and hormone replacement therapy","volume":"24","author":"MacGregor","year":"2018","journal-title":"Post Reprod Health"},{"key":"2021102505540101800_dmab026-B185","first-page":"CD002978","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","volume":"4","author":"Maclennan","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B186","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B187","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ajp.158.2.227","article-title":"Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy","volume":"158","author":"Maki","year":"2001","journal-title":"Am J Psychiatry"},{"key":"2021102505540101800_dmab026-B188","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/GME.0000000000000681","article-title":"Cognition and the menopause transition","volume":"23","author":"Maki","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B189","first-page":"186","article-title":"Changes in muscle mass and strength after menopause","volume":"9","author":"Maltais","year":"2009","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2021102505540101800_dmab026-B190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.2012.04491.x","article-title":"Effects of tibolone or continuous combined oestradiol\/norethisterone acetate on glucose and insulin metabolism","volume":"78","author":"Manassiev","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021102505540101800_dmab026-B191","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1047-2797(92)90011-E","article-title":"A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus","volume":"2","author":"Manson","year":"1992","journal-title":"Ann Epidemiol"},{"key":"2021102505540101800_dmab026-B192","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B193","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.metabol.2012.08.015","article-title":"The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy","volume":"62","author":"Manson","year":"2013","journal-title":"Metabolism"},{"key":"2021102505540101800_dmab026-B194","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended posts stopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B196","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(02)07806-6","article-title":"Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers","volume":"359","author":"Margolis","year":"2002","journal-title":"Lancet"},{"key":"2021102505540101800_dmab026-B197","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"2021102505540101800_dmab026-B198","first-page":"CD004143","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B199","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2021102505540101800_dmab026-B200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.sleep.2012.11.016","article-title":"Do reports of sleep disturbance relate to coronary and aortic calcification in healthy middle-aged women? Study of Women\u2019s Health across the Nation","volume":"14","author":"Matthews","year":"2013","journal-title":"Sleep Med"},{"key":"2021102505540101800_dmab026-B201","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/GME.0000000000001405","article-title":"Lifetime estrogen exposure and cognition in late life: the Cache County Study","volume":"26","author":"Matyi","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NSS.S134864","article-title":"Short- and long-term health consequences of sleep disruption","volume":"9","author":"Medic","year":"2017","journal-title":"Nat Sci Sleep"},{"key":"2021102505540101800_dmab026-B203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0960-0760(00)00110-2","article-title":"Mechanisms of estrogen action in the cardiovascular system","volume":"74","author":"Mendelsohn","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2021102505540101800_dmab026-B204","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2015-1864","article-title":"Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy","volume":"100","author":"Mikkola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B205","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/humrep\/dew014","article-title":"Vaginal estradiol use and the risk for cardiovascular mortality","volume":"31","author":"Mikkola","year":"2016","journal-title":"Hum Reprod"},{"key":"2021102505540101800_dmab026-B206","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/GME.0000000000000698","article-title":"Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study","volume":"23","author":"Mikkola","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B207","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1046\/j.1532-5415.2002.50511.x","article-title":"Mood symptoms and cognitive performance in women estrogen users and nonusers and men","volume":"50","author":"Miller","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"2021102505540101800_dmab026-B208","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12265-009-9104-y","article-title":"Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)","volume":"2","author":"Miller","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"2021102505540101800_dmab026-B209","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/GME.0000000000001167","article-title":"Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study","volume":"26","author":"Miller","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/GME.0000000000001326","article-title":"The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?","volume":"26","author":"Miller","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B211","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13697137.2020.1804545","article-title":"Lessons from KEEPS: the Kronos Early Estrogen Prevention Study","volume":"24","author":"Miller","year":"2020","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00042192-200101000-00004","article-title":"Sleep in menopause: differential effects of two forms of hormone replacement therapy","volume":"8","author":"Montplaisir","year":"2001","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B213","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer","volume":"302","author":"M\u00f8rch","year":"2009","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B214","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-012-9694-6","article-title":"Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?","volume":"27","author":"Morois","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"2021102505540101800_dmab026-B215","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/13697130701460640","article-title":"Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures","volume":"10","author":"Muscat Baron","year":"2007","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B216","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1743-6109.2008.01198.x","article-title":"The use of estrogen therapy in women's sexual functioning (CME)","volume":"6","author":"Nappi","year":"2009","journal-title":"J Sex Med"},{"key":"2021102505540101800_dmab026-B217","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/13697137.2012.657589","article-title":"The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B218","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.maturitas.2016.09.013","article-title":"Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL)","volume":"94","author":"Nappi","year":"2016","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B219","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B220","first-page":"CD009672","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women","volume":"6","author":"Nastri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B221","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B222","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.maturitas.2005.06.008","article-title":"Menopausal symptoms after cessation of hormone replacement therapy","volume":"53","author":"Ness","year":"2006","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B223","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwu347","article-title":"Hormone therapy and young-onset breast cancer","volume":"181","author":"O'Brien","year":"2015","journal-title":"Am J Epidemiol"},{"key":"2021102505540101800_dmab026-B224","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.294.2.183","article-title":"Symptom experience after discontinuing use of estrogen plus progestin","volume":"294","author":"Ockene","year":"2005","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10253890600965773","article-title":"Psychosocial stress impairs working memory at high loads: an association with cortisol levels and memory retrieval","volume":"9","author":"Oei","year":"2006","journal-title":"Stress"},{"key":"2021102505540101800_dmab026-B226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration, and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review","volume":"25","author":"Oliver-Williams","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2021102505540101800_dmab026-B227","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.fertnstert.2016.06.023","article-title":"Effects of hormones on skin wrinkles and rigidity vary by race\/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study","volume":"106","author":"Owen","year":"2016","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B228","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2021102505540101800_dmab026-B229","first-page":"1","article-title":"A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis","volume":"22","author":"Palacios","year":"2015","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13697130701298107","article-title":"Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief","volume":"10","author":"Panay","year":"2007","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B231","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09513590.2014.1003294","article-title":"Clinical effect of hormonal replacement therapy with estradiol associated with norethisterone or drospirenone. A prospective randomized placebo-controlled study","volume":"31","author":"Paoletti","year":"2015","journal-title":"Gynecol Endocrino.l"},{"key":"2021102505540101800_dmab026-B232","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/jc.2017-02449","article-title":"Menopausal hormone therapy is associated with reduced total and visceral adiposity: the OsteoLaus Cohort","volume":"103","author":"Papadakis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B233","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IJWH.S44579","article-title":"Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy","volume":"5","author":"Parish","year":"2013","journal-title":"Int J Women Health"},{"key":"2021102505540101800_dmab026-B234","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses\u2019 Health Study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B235","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1358\/dot.2014.50.5.2134451","article-title":"Ospemifene for the treatment of dyspareunia in postmenopausal women","volume":"50","author":"Paton","year":"2014","journal-title":"Drugs Today"},{"key":"2021102505540101800_dmab026-B236","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13697137.2017.1279141","article-title":"The effects of dehydroepiandrosterone on sexual function: a systematic review","volume":"20","author":"Peixoto","year":"2017","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B237","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tcb.2011.05.001","article-title":"Reconstructing regulatory network transitions","volume":"21","author":"Petricka","year":"2011","journal-title":"Trends Cell Biol"},{"key":"2021102505540101800_dmab026-B238","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaad.2008.05.009","article-title":"Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women","volume":"59","author":"Phillips","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2021102505540101800_dmab026-B239","first-page":"991","article-title":"Predictors of sleep quality in women in the menopausal transition","volume":"31","author":"Pien","year":"2008","journal-title":"Sleep"},{"key":"2021102505540101800_dmab026-B240","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/gme.0b013e3181a816be","article-title":"Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B241","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":"Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial","volume":"121","author":"Pinkerton","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B242","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0b013e31829f05d1","article-title":"Evaluation of the direct and indirect effects of bazedoxifene\/conjugated estrogens on sleep disturbance using mediation modeling","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B243","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/GME.0b013e31829f0433","article-title":"Sleep parameters and health related quality of life with bazedoxifene\/conjugated estrogens: a randomized trial","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B244","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/jc.2013-1707","article-title":"Effects of bazedoxifene\/conjugated estrogens on the endometrium and bone: a randomized trial","volume":"99","author":"Pinkerton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/13697137.2019.1568403","article-title":"Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators","volume":"22","author":"Pinkerton","year":"2019","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B246","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/09513590400021169","article-title":"Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels","volume":"20","author":"Pluchino","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B247","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.maturitas.2008.02.004","article-title":"One-year therapy with 10mg\/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu","volume":"59","author":"Pluchino","year":"2008","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B248","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/gme.0b013e31819b351e","article-title":"Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats","volume":"16","author":"Pluchino","year":"2009","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B249","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s11606-008-0655-4","article-title":"Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis","volume":"23","author":"Politi","year":"2008","journal-title":"J Gen Intern Med"},{"key":"2021102505540101800_dmab026-B250","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B251","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwn044","article-title":"Estrogen plus progestin therapy and breast cancer in recently postmenopausal women","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2021102505540101800_dmab026-B252","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/aje\/kwp115","article-title":"Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause","volume":"170","author":"Prentice","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2021102505540101800_dmab026-B253","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1093\/humrep\/des314","article-title":"Paternal age at birth is associated with offspring leukocyte telomere length in the Nurses\u2019 Health Study","volume":"27","author":"Prescott","year":"2012","journal-title":"Hum Reprod"},{"key":"2021102505540101800_dmab026-B254","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00192-018-3682-7","article-title":"Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy","volume":"30","author":"Rahkola-Soisalo","year":"2019","journal-title":"Int Urogynecol J"},{"key":"2021102505540101800_dmab026-B255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/GME.0000000000001173","article-title":"Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse","volume":"26","author":"Rahkola-Soisalo","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B256","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","article-title":"Vaginal estrogen for genitourinary syndrome of menopause: a systematic review","volume":"124","author":"Rahn","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B257","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Rebbeck","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2021102505540101800_dmab026-B258","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1185\/03007995.2014.890927","article-title":"Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene","volume":"30","author":"Reginster","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"2021102505540101800_dmab026-B259","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case\u2013control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: a population-based study","volume":"8","author":"Renoux","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2021102505540101800_dmab026-B261","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B262","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B263","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/IJGM.S46310","article-title":"Prevention and treatment of venous thromboembolism during HRT: current perspectives","volume":"7","author":"Rott","year":"2014","journal-title":"Int J Gen Med"},{"key":"2021102505540101800_dmab026-B264","article-title":"The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue","volume":"37","author":"Ruan","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2021102505540101800_dmab026-B265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/da.22391","article-title":"Efficacy of estradiol in perimenopausal depression: so much promise and so few answers","volume":"32","author":"Rubinow","year":"2015","journal-title":"Depress Anxiety"},{"key":"2021102505540101800_dmab026-B266","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/cmt.5.4.390.398","article-title":"Ten years of treatment with tibolone 2.5 mg daily: 283 effects on bone loss in postmenopausal women","volume":"5","author":"Rymer","year":"2002","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B267","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"2021102505540101800_dmab026-B268","doi-asserted-by":"crossref","first-page":"e0194015","DOI":"10.1371\/journal.pone.0194015","article-title":"The impact of menopausal hormone therapy (MHT) on cardiac structure and function: insights from the UK Biobank imaging enhancement study","volume":"13","author":"Sanghvi","year":"2018","journal-title":"PLoS One"},{"key":"2021102505540101800_dmab026-B269","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1055-9965.EPI-12-0043","article-title":"Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy","volume":"21","author":"Santen","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021102505540101800_dmab026-B270","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing menopausal symptoms and associated clinical issues in breast cancer survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B271","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/GME.0000000000000557","article-title":"Use of a levonorgestrel-containing intrauterine system with supplemental estrogen improves symptoms in perimenopausal women: a pilot study","volume":"22","author":"Santoro","year":"2015","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B272","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/GME.0000000000000756","article-title":"Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study","volume":"24","author":"Santoro","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B273","doi-asserted-by":"crossref","first-page":"h5746","DOI":"10.1136\/bmj.h5746","article-title":"Diagnosis and management of menopause: summary of NICE guidance","volume":"351","author":"Sarri","year":"2015","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B274","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.maturitas.2018.07.016","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase","volume":"116","author":"Sauer","year":"2018","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B275","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2015-4149","article-title":"Cardiac death risk in relation to the age at initiation or the progestin component of hormone therapies","volume":"101","author":"Savolainen-Peltonen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B276","doi-asserted-by":"crossref","first-page":"l665","DOI":"10.1136\/bmj.l665","article-title":"Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study","volume":"364","author":"Savolainen-Peltonen","year":"2019","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B277","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4088\/JCP.09m05188blu","article-title":"A prospective study of hormone therapy and depression in community-dwelling elderly women: the Three City Study","volume":"71","author":"Scali","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2021102505540101800_dmab026-B278","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/13697137.2018.1446931","article-title":"Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis","volume":"21","author":"Scarabin","year":"2018","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B279","first-page":"CD011066","article-title":"Dehydroepiandrosterone for women in the peri- or postmenopausal phase","volume":"1","author":"Scheffers","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B280","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B281","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamapsychiatry.2015.0111","article-title":"Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial","volume":"72","author":"Schmidt","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2021102505540101800_dmab026-B282","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13697130902780853","article-title":"Risk of cardiovascular outcomes in users of estradiol\/dydrogesterone or other HRT preparations","volume":"12","author":"Schneider","year":"2009","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B283","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","article-title":"Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study","volume":"79","author":"Shao","year":"2012","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B284","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jcem-72-2-336","article-title":"The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women","volume":"72","author":"Sherwin","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2001-0016","article-title":"Estrogen and cognitive functioning in women","volume":"24","author":"Sherwin","year":"2003","journal-title":"Endocr Rev"},{"key":"2021102505540101800_dmab026-B286","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/GME.0b013e31829a64f9","article-title":"Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women\u2019s Health Initiative Observational Study","volume":"21","author":"Shufelt","year":"2014","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B287","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B288","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","article-title":"Menopausal hormone therapy and cancer risk: an overestimated risk?","volume":"84","author":"Simin","year":"2017","journal-title":"Eur J Cancer"},{"key":"2021102505540101800_dmab026-B289","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B290","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/GME.0000000000000590","article-title":"Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy","volume":"23","author":"Simon","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B291","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/GME.0000000000001271","article-title":"Oral 17\u03b2-estradiol\/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms","volume":"26","author":"Simon","year":"2019","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B292","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/CS20000271","article-title":"Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study","volume":"101","author":"Sipila","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"2021102505540101800_dmab026-B293","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2004-1479","article-title":"The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial","volume":"90","author":"Sites","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B294","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/09513590.2017.1371129","article-title":"Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause","volume":"34","author":"Slopien","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2021102505540101800_dmab026-B295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2018.08.009","article-title":"Menopause and diabetes: EMAS clinical guide","volume":"117","author":"Slopien","year":"2018","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B296","first-page":"CD004509","article-title":"Testosterone for peri and postmenopausal women","volume":"4","author":"Somboonporn","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2021102505540101800_dmab026-B297","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10654-015-0016-7","article-title":"Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women","volume":"30","author":"Sommer","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"2021102505540101800_dmab026-B298","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/oby.2001.81","article-title":"Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy","volume":"9","author":"Sorensen","year":"2001","journal-title":"Obes Res"},{"key":"2021102505540101800_dmab026-B299","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/jc.2018-01600","article-title":"Differential effect of plasma estradiol on subclinical atherosclerosis progression in early vs late postmenopause","volume":"104","author":"Sriprasert","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B300","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","article-title":"A prospective study of postmenopausal estrogen therapy and coronary heart disease","volume":"313","author":"Stampfer","year":"1985","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B301","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","article-title":"Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration","volume":"118 Suppl 12B","author":"Stefanick","year":"2005","journal-title":"Am J Med"},{"key":"2021102505540101800_dmab026-B302","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.maturitas.2010.07.002","article-title":"Oral ultra-low 17. dose continuous combined hormone replacement therapy with 0.5 mg 17 \u03b2 -oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study","volume":"67","author":"Stevenson","year":"2010","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B303","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-5122(97)00073-X","article-title":"Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women","volume":"28","author":"Stomati","year":"1997","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B304","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-5122(02)00205-0","article-title":"Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin","volume":"43","author":"Stomati","year":"2002","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","article-title":"Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study","volume":"13","author":"Swanson","year":"2006","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B306","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","volume":"10","author":"Sweetland","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2021102505540101800_dmab026-B307","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GME.0000000000001067","article-title":"Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials","volume":"25","author":"Swica","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B308","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/13697130903004758","article-title":"Blood pressure through aging and menopause","volume":"12 Suppl 1","author":"Taddei","year":"2009","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B309","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/092986709788186093","article-title":"Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels","volume":"16","author":"Smiley","year":"2009","journal-title":"Curr Med Chem"},{"key":"2021102505540101800_dmab026-B310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cercor\/bhg121","article-title":"Estrogen replacement increases spinophilin immunoreactive spine number in the prefrontal cortex of female rhesus monkeys","volume":"14","author":"Tang","year":"2004","journal-title":"Cereb Cortex"},{"key":"2021102505540101800_dmab026-B311","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamainternmed.2017.3877","article-title":"Effects of oral vs. transdermal estrogen therapy on sexual function in early postmenopause: ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS)","volume":"177","author":"Taylor","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2021102505540101800_dmab026-B312","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B313","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B314","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/ progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen\/progestin Interventions (PEPI) trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B315","doi-asserted-by":"crossref","first-page":"137e1","DOI":"10.1016\/j.ajog.2007.05.042","article-title":"Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women\u2019s Health, Osteoporosis, Progestin, Estrogen (HOPE) trial","volume":"197","author":"Thorneycroft","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B316","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.108.776823","article-title":"Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study","volume":"118","author":"Thurston","year":"2008","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B317","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/gme.0b013e3181fa27fd","article-title":"Hot flashes and carotid intima media thickness among midlife women","volume":"18","author":"Thurston","year":"2011","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B318","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw052","article-title":"Sleep characteristics and carotid atherosclerosis among midlife women","volume":"40","author":"Thurston","year":"2017","journal-title":"Sleep"},{"key":"2021102505540101800_dmab026-B319","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/clinem\/dgaa081","article-title":"Vasomotor symptoms and accelerated epigenetic aging in the Women's Health Initiative (WHI)","volume":"105","author":"Thurston","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B320","doi-asserted-by":"crossref","first-page":"378.e1","DOI":"10.1016\/j.ajog.2009.11.021","article-title":"The incidence of urinary incontinence across Asian, black, and white women in the United States","volume":"202","author":"Townsend","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2021102505540101800_dmab026-B321","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853890.2013.854982","article-title":"Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women","volume":"46","author":"Tuomikoski","year":"2014","journal-title":"Ann Med"},{"key":"2021102505540101800_dmab026-B322","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/GME.0b013e318298debe","article-title":"Impact of hormone therapy on quality of life after menopause","volume":"20","author":"Utian","year":"2013","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B323","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/GME.0000000000001223","article-title":"The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause","volume":"25","author":"Utian","year":"2018","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B324","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.fertnstert.2003.07.041","article-title":"Effects of 287 tibolone and continuous combined hormone therapy on mammographic breast density and 288 breast histochemical markers in postmenopausal women","volume":"81","author":"Valdivia","year":"2004","journal-title":"Fertil Steril"},{"key":"2021102505540101800_dmab026-B325","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.55.6.872","article-title":"Cognitive performance in surgically menopausal women on estrogen","volume":"55","author":"Verghese","year":"2000","journal-title":"Neurology"},{"key":"2021102505540101800_dmab026-B327","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B328","first-page":"302","article-title":"No increase in fractures after stopping hormone therapy: results from the Women's Health Initiative","volume":"102","author":"Watts","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2021102505540101800_dmab026-B329","doi-asserted-by":"crossref","first-page":"a1190","DOI":"10.1136\/bmj.a1190","article-title":"Health related quality of life after combined hormone replacement therapy: randomised controlled trial","volume":"337","author":"Welton","year":"2008","journal-title":"BMJ"},{"key":"2021102505540101800_dmab026-B330","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17 beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"2021102505540101800_dmab026-B331","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/gme.0b013e31826f80e0","article-title":"Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women\u2019s Health Initiative randomized clinical trials","volume":"20","author":"Wild","year":"2013","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B332","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.22239","article-title":"Timing of hormone therapy and dementia: the critical window theory revisited","volume":"69","author":"Whitmer","year":"2011","journal-title":"Ann Neurol"},{"key":"2021102505540101800_dmab026-B333","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00097-5","article-title":"17\u03b2-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells","volume":"1406","author":"Wingrove","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2021102505540101800_dmab026-B334","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women\u2019s lives","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"2021102505540101800_dmab026-B335","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B336","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.maturitas.2013.05.010","article-title":"Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials","volume":"75","author":"Yang","year":"2013","journal-title":"Maturitas"},{"key":"2021102505540101800_dmab026-B337","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neubiorev.2015.04.005","article-title":"Actions and interactions of estradiol and glucocorticoids in cognition and the brain: implications for aging women","volume":"55","author":"Ycaza Herrera","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"2021102505540101800_dmab026-B338","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer\u2019s disease in older women","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"},{"key":"2021102505540101800_dmab026-B339","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/13697130903395201","article-title":"Low-dose hormone therapy in postmenopausal women in China","volume":"13","author":"Zang","year":"2010","journal-title":"Climacteric"},{"key":"2021102505540101800_dmab026-B340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5414\/CPP39041","article-title":"Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets","volume":"39","author":"Zdravkovic","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2021102505540101800_dmab026-B341","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/GME.0000000000000519","article-title":"Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Zhu","year":"2016","journal-title":"Menopause"},{"key":"2021102505540101800_dmab026-B342","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial carcinoma among users of conjugated estrogens","volume":"293","author":"Ziel","year":"1975","journal-title":"N Engl J Med"},{"key":"2021102505540101800_dmab026-B343","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0306-4530(96)00034-0","article-title":"A meta-analysis of the effect of hormone replacement therapy upon depressed mood","volume":"22","author":"Zweifel","year":"1997","journal-title":"Psychoneuroendocrinology"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/6\/1115\/40724074\/dmab026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/6\/1115\/40724074\/dmab026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T17:05:23Z","timestamp":1699203923000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/27\/6\/1115\/6357317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":344,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,8,25]]},"published-print":{"date-parts":[[2021,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmab026","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,8,25]]}}}